SteelPeak Wealth LLC Invests $635,000 in Omnicell, Inc. (NASDAQ:OMCL)

SteelPeak Wealth LLC acquired a new stake in shares of Omnicell, Inc. (NASDAQ:OMCL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 14,271 shares of the company's stock, valued at approximately $635,000.

Other hedge funds have also recently made changes to their positions in the company. Pier Capital LLC purchased a new position in shares of Omnicell during the third quarter valued at approximately $5,859,000. Royce & Associates LP purchased a new position in shares of Omnicell during the third quarter valued at approximately $811,000. Geode Capital Management LLC raised its holdings in shares of Omnicell by 0.3% during the third quarter. Geode Capital Management LLC now owns 1,104,745 shares of the company's stock valued at $48,176,000 after purchasing an additional 2,877 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in Omnicell by 750.5% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 294,037 shares of the company's stock valued at $12,820,000 after buying an additional 259,463 shares during the last quarter. Finally, Intech Investment Management LLC purchased a new stake in Omnicell during the third quarter valued at approximately $753,000. 97.70% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Omnicell news, Director Mark W. Parrish sold 12,000 shares of the stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $47.30, for a total transaction of $567,600.00. Following the completion of the transaction, the director now owns 58,427 shares in the company, valued at $2,763,597.10. This trade represents a 17.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.64% of the stock is owned by company insiders.

Omnicell Trading Down 3.5 %

Shares of NASDAQ:OMCL traded down $1.57 during midday trading on Monday, reaching $43.42. 351,821 shares of the company were exchanged, compared to its average volume of 322,306. The business's fifty day moving average is $44.69 and its two-hundred day moving average is $42.99. Omnicell, Inc. has a one year low of $25.12 and a one year high of $55.74. The stock has a market cap of $2.01 billion, a PE ratio of -111.33, a price-to-earnings-growth ratio of 30.78 and a beta of 0.78.

Wall Street Analyst Weigh In

A number of brokerages have commented on OMCL. StockNews.com cut shares of Omnicell from a "buy" rating to a "hold" rating in a report on Tuesday, December 10th. Craig Hallum increased their price objective on shares of Omnicell from $45.00 to $64.00 and gave the stock a "buy" rating in a research note on Thursday, October 31st. JPMorgan Chase & Co. increased their price objective on shares of Omnicell from $37.00 to $44.00 and gave the stock a "neutral" rating in a research note on Thursday, November 21st. Wells Fargo & Company reduced their price objective on shares of Omnicell from $49.00 to $40.00 and set an "equal weight" rating for the company in a research note on Monday, January 13th. Finally, Benchmark reissued a "buy" rating and issued a $48.00 price objective on shares of Omnicell in a research note on Wednesday, October 9th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Omnicell has an average rating of "Hold" and an average price target of $50.00.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.